nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—PTGS2—Dapsone—malaria	0.084	0.0897	CbGbCtD
Lumiracoxib—CYP2C19—Artemether—malaria	0.0748	0.0799	CbGbCtD
Lumiracoxib—CYP2C9—Sulfadiazine—malaria	0.0731	0.0781	CbGbCtD
Lumiracoxib—CYP2C9—Pyrimethamine—malaria	0.0731	0.0781	CbGbCtD
Lumiracoxib—PTGS1—Dapsone—malaria	0.0709	0.0758	CbGbCtD
Lumiracoxib—CYP2C19—Proguanil—malaria	0.0703	0.0751	CbGbCtD
Lumiracoxib—CYP1A2—Proguanil—malaria	0.0649	0.0693	CbGbCtD
Lumiracoxib—CYP2C9—Artemether—malaria	0.0622	0.0664	CbGbCtD
Lumiracoxib—CYP2C9—Proguanil—malaria	0.0585	0.0625	CbGbCtD
Lumiracoxib—CYP1A2—Pentoxifylline—malaria	0.0466	0.0498	CbGbCtD
Lumiracoxib—CYP2C19—Quinine—malaria	0.0453	0.0484	CbGbCtD
Lumiracoxib—CYP1A2—Quinine—malaria	0.0418	0.0447	CbGbCtD
Lumiracoxib—CYP2C9—Quinine—malaria	0.0377	0.0403	CbGbCtD
Lumiracoxib—CYP1A2—Quinidine—malaria	0.0367	0.0393	CbGbCtD
Lumiracoxib—CYP2C19—Dapsone—malaria	0.0343	0.0367	CbGbCtD
Lumiracoxib—CYP2C9—Quinidine—malaria	0.0331	0.0354	CbGbCtD
Lumiracoxib—CYP2C9—Dapsone—malaria	0.0286	0.0305	CbGbCtD
Lumiracoxib—UGT1A9—kidney—malaria	0.00435	0.0769	CbGeAlD
Lumiracoxib—UGT1A9—digestive system—malaria	0.00369	0.0652	CbGeAlD
Lumiracoxib—CYP2C19—blood plasma—malaria	0.00356	0.063	CbGeAlD
Lumiracoxib—CYP1A2—blood plasma—malaria	0.00291	0.0515	CbGeAlD
Lumiracoxib—PTGS1—endothelium—malaria	0.00284	0.0502	CbGeAlD
Lumiracoxib—CYP2C9—blood plasma—malaria	0.00276	0.0489	CbGeAlD
Lumiracoxib—UGT1A9—liver—malaria	0.00275	0.0486	CbGeAlD
Lumiracoxib—PTGS2—endothelium—malaria	0.00271	0.048	CbGeAlD
Lumiracoxib—PTGS1—blood plasma—malaria	0.00252	0.0446	CbGeAlD
Lumiracoxib—PTGS2—blood plasma—malaria	0.00241	0.0426	CbGeAlD
Lumiracoxib—CYP2C19—hematopoietic system—malaria	0.00197	0.0349	CbGeAlD
Lumiracoxib—CYP1A2—hematopoietic system—malaria	0.00161	0.0285	CbGeAlD
Lumiracoxib—CYP2C9—hematopoietic system—malaria	0.00153	0.027	CbGeAlD
Lumiracoxib—PTGS1—hematopoietic system—malaria	0.00139	0.0247	CbGeAlD
Lumiracoxib—CYP2C19—digestive system—malaria	0.00137	0.0242	CbGeAlD
Lumiracoxib—PTGS2—hematopoietic system—malaria	0.00133	0.0236	CbGeAlD
Lumiracoxib—CYP2C19—blood—malaria	0.0013	0.0231	CbGeAlD
Lumiracoxib—PTGS1—kidney—malaria	0.00114	0.0202	CbGeAlD
Lumiracoxib—CYP1A2—digestive system—malaria	0.00112	0.0198	CbGeAlD
Lumiracoxib—PTGS2—kidney—malaria	0.00109	0.0193	CbGeAlD
Lumiracoxib—CYP1A2—blood—malaria	0.00107	0.0189	CbGeAlD
Lumiracoxib—CYP2C9—digestive system—malaria	0.00106	0.0188	CbGeAlD
Lumiracoxib—CYP2C19—liver—malaria	0.00102	0.0181	CbGeAlD
Lumiracoxib—CYP2C9—blood—malaria	0.00101	0.0179	CbGeAlD
Lumiracoxib—PTGS1—digestive system—malaria	0.00097	0.0172	CbGeAlD
Lumiracoxib—PTGS2—digestive system—malaria	0.000927	0.0164	CbGeAlD
Lumiracoxib—PTGS1—blood—malaria	0.000924	0.0163	CbGeAlD
Lumiracoxib—PTGS2—blood—malaria	0.000883	0.0156	CbGeAlD
Lumiracoxib—PTGS2—bone marrow—malaria	0.000854	0.0151	CbGeAlD
Lumiracoxib—CYP1A2—liver—malaria	0.000833	0.0148	CbGeAlD
Lumiracoxib—CYP2C9—liver—malaria	0.000791	0.014	CbGeAlD
Lumiracoxib—PTGS2—liver—malaria	0.00069	0.0122	CbGeAlD
Lumiracoxib—PTGS1—brain—malaria	0.000573	0.0101	CbGeAlD
Lumiracoxib—PTGS2—brain—malaria	0.000548	0.00969	CbGeAlD
Lumiracoxib—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—malaria	0.000476	0.063	CbGpPWpGaD
Lumiracoxib—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—malaria	0.000378	0.05	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—CRP—malaria	0.000194	0.0256	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	0.00019	0.0252	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—HBB—malaria	0.00018	0.0239	CbGpPWpGaD
Lumiracoxib—PTGS1—Arachidonic acid metabolism—HPGDS—malaria	0.000172	0.0228	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—CRP—malaria	0.000154	0.0204	CbGpPWpGaD
Lumiracoxib—PTGS2—S1P1 pathway—KDR—malaria	0.000147	0.0195	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000146	0.0193	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—HBB—malaria	0.000143	0.019	CbGpPWpGaD
Lumiracoxib—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—DECR1—malaria	0.000138	0.0183	CbGpPWpGaD
Lumiracoxib—PTGS2—Arachidonic acid metabolism—HPGDS—malaria	0.000136	0.0181	CbGpPWpGaD
Lumiracoxib—UGT1A9—Phase II conjugation—HPGDS—malaria	0.000134	0.0178	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—malaria	0.00013	0.0173	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—malaria	0.000127	0.0168	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—G6PD—malaria	0.000117	0.0155	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—SCARB1—malaria	0.0001	0.0133	CbGpPWpGaD
Lumiracoxib—CYP2C19—Arachidonic acid metabolism—HPGDS—malaria	9.9e-05	0.0131	CbGpPWpGaD
Lumiracoxib—CYP2C9—Arachidonic acid metabolism—HPGDS—malaria	9.03e-05	0.012	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—TNF—malaria	8.76e-05	0.0116	CbGpPWpGaD
Lumiracoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—malaria	8.59e-05	0.0114	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—malaria	8.43e-05	0.0112	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—CD36—malaria	8.4e-05	0.0111	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—malaria	8.25e-05	0.0109	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—malaria	8.2e-05	0.0109	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	8.18e-05	0.0108	CbGpPWpGaD
Lumiracoxib—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—malaria	8.12e-05	0.0108	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—SCARB1—malaria	7.97e-05	0.0106	CbGpPWpGaD
Lumiracoxib—UGT1A9—Biological oxidations—HPGDS—malaria	7.84e-05	0.0104	CbGpPWpGaD
Lumiracoxib—CYP1A2—Arachidonic acid metabolism—HPGDS—malaria	7.72e-05	0.0102	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—malaria	7.66e-05	0.0102	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	7.3e-05	0.00967	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	7.27e-05	0.00964	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—IL6—malaria	7.07e-05	0.00937	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	6.97e-05	0.00924	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—TNF—malaria	6.95e-05	0.00922	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—FCGR2A—malaria	6.86e-05	0.00909	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—malaria	6.81e-05	0.00902	CbGpPWpGaD
Lumiracoxib—UGT1A9—PPARA activates gene expression—CD36—malaria	6.46e-05	0.00856	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—HPGDS—malaria	6.39e-05	0.00847	CbGpPWpGaD
Lumiracoxib—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—malaria	6.32e-05	0.00838	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—CRP—malaria	5.68e-05	0.00752	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—IL6—malaria	5.61e-05	0.00744	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—DECR1—malaria	5.5e-05	0.00729	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	5.3e-05	0.00702	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—ICAM1—malaria	5.22e-05	0.00692	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malaria	4.95e-05	0.00657	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase II conjugation—HPGDS—malaria	4.91e-05	0.00651	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—CD36—malaria	4.75e-05	0.0063	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	4.67e-05	0.00619	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—CRP—malaria	4.51e-05	0.00597	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—DECR1—malaria	4.48e-05	0.00594	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malaria	4.4e-05	0.00583	CbGpPWpGaD
Lumiracoxib—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—malaria	4.36e-05	0.00578	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—ICAM1—malaria	4.14e-05	0.00549	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL4—malaria	4.12e-05	0.00547	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—IFNG—malaria	3.97e-05	0.00526	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—HPGDS—malaria	3.69e-05	0.00489	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—DECR1—malaria	3.56e-05	0.00471	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—IL1B—malaria	3.54e-05	0.00469	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—TNF—malaria	3.43e-05	0.00454	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TLR4—malaria	3.42e-05	0.00453	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—HPGDS—malaria	3.36e-05	0.00445	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—ICAM1—malaria	3.28e-05	0.00434	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—NOS2—malaria	3.25e-05	0.00431	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malaria	3.21e-05	0.00425	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—CD4—malaria	3.16e-05	0.00419	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IFNG—malaria	3.15e-05	0.00418	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—DHODH—malaria	3.06e-05	0.00406	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.01e-05	0.00399	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	3e-05	0.00397	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—HPGDS—malaria	2.87e-05	0.00381	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IL1B—malaria	2.81e-05	0.00373	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.77e-05	0.00366	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	2.67e-05	0.00354	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	2.66e-05	0.00353	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—SLC4A1—malaria	2.6e-05	0.00345	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—malaria	2.59e-05	0.00343	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—DECR1—malaria	2.58e-05	0.00342	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—TNF—malaria	2.57e-05	0.00341	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—DHODH—malaria	2.5e-05	0.00331	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IFNG—malaria	2.49e-05	0.0033	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.46e-05	0.00325	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—DECR1—malaria	2.45e-05	0.00324	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—DECR1—malaria	2.36e-05	0.00312	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.25e-05	0.00299	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL1B—malaria	2.22e-05	0.00295	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL2—malaria	2.21e-05	0.00294	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—HBB—malaria	2.21e-05	0.00293	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—SLC4A1—malaria	2.12e-05	0.00281	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—IL6—malaria	2.07e-05	0.00275	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—TNF—malaria	2.04e-05	0.0027	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—DECR1—malaria	2.01e-05	0.00267	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—DECR1—malaria	2e-05	0.00264	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—DHODH—malaria	1.98e-05	0.00263	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PKLR—malaria	1.97e-05	0.00262	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—malaria	1.95e-05	0.00258	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	1.94e-05	0.00257	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malaria	1.94e-05	0.00257	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—HBB—malaria	1.8e-05	0.00239	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.79e-05	0.00237	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—G6PD—malaria	1.76e-05	0.00233	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—CD36—malaria	1.74e-05	0.0023	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—SLC4A1—malaria	1.68e-05	0.00223	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IL6—malaria	1.65e-05	0.00218	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TNF—malaria	1.61e-05	0.00214	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PKLR—malaria	1.61e-05	0.00213	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—DECR1—malaria	1.58e-05	0.0021	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PKLR—malaria	1.52e-05	0.00202	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—DHODH—malaria	1.44e-05	0.00191	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—G6PD—malaria	1.43e-05	0.0019	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—HBB—malaria	1.43e-05	0.0019	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—malaria	1.42e-05	0.00188	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—CD36—malaria	1.41e-05	0.00187	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—G6PD—malaria	1.36e-05	0.0018	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—HPGDS—malaria	1.34e-05	0.00178	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—DHODH—malaria	1.31e-05	0.00174	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL6—malaria	1.3e-05	0.00173	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.3e-05	0.00172	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—malaria	1.29e-05	0.00171	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PKLR—malaria	1.28e-05	0.00169	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—DHFR—malaria	1.24e-05	0.00165	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—SCARB1—malaria	1.23e-05	0.00163	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SLC4A1—malaria	1.22e-05	0.00162	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.19e-05	0.00157	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—DECR1—malaria	1.15e-05	0.00152	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—G6PD—malaria	1.14e-05	0.00151	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—CD36—malaria	1.12e-05	0.00149	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—DHODH—malaria	1.12e-05	0.00149	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SLC4A1—malaria	1.12e-05	0.00148	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	1.1e-05	0.00146	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malaria	1.1e-05	0.00145	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—HPGDS—malaria	1.09e-05	0.00145	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—DECR1—malaria	1.05e-05	0.00139	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—HBB—malaria	1.04e-05	0.00138	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—DHFR—malaria	1.01e-05	0.00134	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.01e-05	0.00134	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—SCARB1—malaria	1e-05	0.00133	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—DHFR—malaria	9.62e-06	0.00127	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SLC4A1—malaria	9.54e-06	0.00126	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—HBB—malaria	9.49e-06	0.00126	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PKLR—malaria	9.27e-06	0.00123	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—DECR1—malaria	8.97e-06	0.00119	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—HPGDS—malaria	8.68e-06	0.00115	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PKLR—malaria	8.46e-06	0.00112	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—G6PD—malaria	8.27e-06	0.0011	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—CD36—malaria	8.16e-06	0.00108	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—HBB—malaria	8.11e-06	0.00107	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—DHFR—malaria	8.05e-06	0.00107	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—SCARB1—malaria	7.97e-06	0.00106	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CD36—malaria	7.73e-06	0.00102	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—G6PD—malaria	7.54e-06	0.000999	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—CD36—malaria	7.44e-06	0.000986	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PKLR—malaria	7.23e-06	0.000958	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—G6PD—malaria	6.44e-06	0.000854	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CD36—malaria	6.36e-06	0.000842	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—HPGDS—malaria	6.3e-06	0.000836	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CD36—malaria	6.3e-06	0.000835	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—DHFR—malaria	5.85e-06	0.000775	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SCARB1—malaria	5.79e-06	0.000767	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—HPGDS—malaria	5.75e-06	0.000762	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—DHFR—malaria	5.33e-06	0.000707	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SCARB1—malaria	5.28e-06	0.000699	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CD36—malaria	5e-06	0.000663	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—HPGDS—malaria	4.91e-06	0.000651	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NOS2—malaria	4.91e-06	0.000651	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—DHFR—malaria	4.56e-06	0.000604	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SCARB1—malaria	4.51e-06	0.000598	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CD4—malaria	3.64e-06	0.000482	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CD36—malaria	3.63e-06	0.000481	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CD36—malaria	3.31e-06	0.000439	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CD36—malaria	2.83e-06	0.000375	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IL6—malaria	1.97e-06	0.000261	CbGpPWpGaD
